M
$ Value
$0
Shares
2,159
Price
$0
Filed
Jun 6
Insider
Name
YOUNGBLOOD DR KNEELAND
Title
—
CIK
0001137820
Roles
Director
Transaction Details
Transaction Date
2025-06-05
Code
M
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Represents the vesting of restricted stock units granted on June 5, 2024. The award has fully vested. Each restricted stock unit converted into a share of common stock on a one-for-one basis.
Filing Info
YOUNGBLOOD DR KNEELAND's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2025-06-10 | LNW | A | $0 |
| 2025-06-05 | LNW | M | $0 |
| 2025-06-05 | LNW | M | $0 |
Other Insiders at LNW (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| Morro Stephen W | — | — | 2026-03-12 |
| Fine Capital Partners, L.P. | — | $1.7M | 2026-01-27 |
|
Wilson Matthew R.
President & CEO
|
— | — | 2026-03-20 |
| McLennan Hamish | — | $542K | 2026-03-12 |
|
Lane Siobhan
SVP & CEO - Gaming
|
— | $2.7M | 2026-03-20 |
|
Kalabic Vanja
SVP & Chief Accounting Officer
|
— | $137K | 2026-03-20 |
|
Chow Oliver
EVP, CFO & Treas
|
— | $464K | 2026-03-20 |